Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.160
+0.050 (2.37%)
Aug 4, 2026, 1:37 PM EDT - Market open

Lipocine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
184926153588
Market Cap Growth
5.37%89.49%75.97%-57.92%-59.94%-7.63%
Enterprise Value
-5.8734.524.46-7.22.7245.68
Last Close Price
2.168.034.882.796.7716.85

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.757.757.757.757.75
PS Ratio
11.0825.022.334.8370.50-
PB Ratio
0.693.421.240.730.991.93
P/TBV Ratio
0.673.171.260.721.001.91

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-17.460.40-2.355.44-
EV/EBITDA Ratio
---0.40-14.52
EV/EBIT Ratio
---0.40-14.52
EV/FCF Ratio
---0.61--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / EBITDA Ratio
-----0.74
Net Debt / Equity Ratio
-1.07-1.03-1.03-1.08-0.91-0.93
Net Debt / EBITDA Ratio
1.861.4519.421.232.69-13.45
Net Debt / FCF Ratio
2.081.5316.501.862.699.57
Asset Turnover
0.080.100.490.100.010
Quick Ratio
11.396.3614.448.3919.437.99
Current Ratio
11.486.6814.758.6920.348.26
Return on Equity (ROE)
-65.40%-54.28%0.04%-58.40%-26.50%-2.08%
Return on Assets (ROA)
-61.55%-52.49%-4.69%-59.24%-26.93%8.09%
Return on Invested Capital (ROIC)
----2492.38%-380.66%138.98%
Return on Capital Employed (ROCE)
-69.35%-58.47%-5.58%-63.77%-29.30%9.58%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-22.05%-5.27%-2.90%-0.26%-1.98%-57.35%
Total Shareholder Return
-22.05%-5.27%-2.90%-0.26%-1.98%-57.35%
SEC Filings: 10-K · 10-Q